Study to Assess Antiviral Antibody Cocktail for COVID-19 Prevention Begins - Monthly Prescribing Reference

A phase 3 trial evaluating an investigational antiviral antibody cocktail, REGN-COV2, for the prevention of COVID-19 has been initiated by Regeneron Pharmaceuticals.

Study to Assess Antiviral Antibody Cocktail for COVID-19 Prevention Begins - Monthly Prescribing Reference


SOURCE: Empr.com

Click here to READ THE FULL STORY.